Sera Prognostics Inc

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Sera Prognostics Inc
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Frequently asked questions
To buy Sera Prognostics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sera Prognostics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sera Prognostics Inc is SERA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sera Prognostics Inc has its primary listing on NASDAQ. You can trade Sera Prognostics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sera Prognostics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Sera Prognostics Inc as part of a broader investment portfolio.